N-(2-(3,4-Dimethoxyphenyl)ethyl)-2-nitriloethanamide, 98%, 98.0%, 1g

1-(4-(Trifluoromethyl)pyridin-2-yl)cyclopropan-1-amine dihydrochloride, 98%, 1g

(2R,3R)-3-Amino-2-hydroxy-3-(o-tolyl)propanoic acid, 95.0%, 250mg

(1R)-1-(2,4,6-TRIMETHYLPHENYL)ETHAN-1-AMINE HYDROCHLORIDE, 95%, 100mg

2,6-Dichlorophenyl 3,3,3-trifluoropropyl sulfide, 25g

2,5-Dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxylate, 95.0%, 25g

2-{[(4-fluorophenyl)amino]methyl}phenol, 95+%, 100mg

2-Bromo-4-(tert-butyl)-6-fluoroaniline, 97.0%, 100mg

{2-bromo-4-[(2-chlorophenyl)methoxy]-5-methoxyphenyl}methanamine, 97%, 250mg

Quinoxaline>99.0%(GC)25g

Pipeta de desplazamiento directo Transferpettor digital, 200 a 1000 µl, 1 pieza

ethyl 1-methyl-4-nitro-1H-pyrazole-5-carboxylate, 97.0%, 1g

Phosphoric acid tris(1H,1H,5H-octafluoro-n-pentyl)ester, 85.0%, 10g